Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Critical Issues in the Management of CRMS/CFSPID Children: A National Real-World Survey.
Terlizzi V, Fevola C, Presti S, Claut L, Ambroni M, Calderazzo MA, Esposito I, Fabrizzi B, Leonetti G, Lombardo M, Maschio M, Palladino N, Pauro F, Pisi G, Ripani P, Ros M, Rotolo N, Salvatore D, Sepe A, Termini L, Timpano S, Troiani P, Vitullo P, Zanda M, Blasi F, Castellani C. Terlizzi V, et al. Among authors: fevola c. Pediatr Pulmonol. 2025 Jan;60(1):e27483. doi: 10.1002/ppul.27483. Pediatr Pulmonol. 2025. PMID: 39812351 Free PMC article.
Effect of elexacaftor-tezacaftor-ivacaftor on liver transient elastography, fibrosis indices and blood tests in children with cystic fibrosis.
Terlizzi V, Fevola C, Cecchetti M, Terminiello A, Curci F, Bartolini E, Rubino C, Stinco M, Carrera S, Bonomi P, Taccetti G, Sellers ZM, Indolfi G. Terlizzi V, et al. Among authors: fevola c. J Cyst Fibros. 2025 Jan 12:S1569-1993(24)01861-7. doi: 10.1016/j.jcf.2024.12.010. Online ahead of print. J Cyst Fibros. 2025. PMID: 39800644
Antibiotic treatment of bacterial lung infections in cystic fibrosis.
Taccetti G, Terlizzi V, Campana S, Dolce D, Ravenni N, Fevola C, Francalanci M, Galici V, Neri AS. Taccetti G, et al. Among authors: fevola c. Eur J Pediatr. 2024 Dec 14;184(1):82. doi: 10.1007/s00431-024-05905-9. Eur J Pediatr. 2024. PMID: 39672981 Free PMC article. Review.
Pharmacological rescue of the G85E CFTR variant by preclinical and approved modulators.
Tomati V, Capurro V, Pesce E, Pastorino C, Sondo E, Lena M, Borrelli A, Cresta F, Pantano S, Collini F, Ripani P, Terlizzi V, Fevola C, Costa S, Lucanto MC, Zara F, Bandiera T, Bocciardi R, Castellani C, Galietta LJV, Pedemonte N. Tomati V, et al. Among authors: fevola c. Front Pharmacol. 2024 Nov 18;15:1494327. doi: 10.3389/fphar.2024.1494327. eCollection 2024. Front Pharmacol. 2024. PMID: 39624835 Free PMC article.
Corrigendum to "Reported Adverse Events in a Multicenter Cohort of Patients Ages 6-18 years with Cystic Fibrosis and at Least one F508dek Allele Receiving Elexacaftor/Tezacaftor/Ivacaftor". J Pediatr. 2024 Jun 28; 274:114176.
Terlizzi V, Fevola C, Presti S, Castaldo A, Daccò V, Claut L, Sepe A, Majo F, Casciaro R, Esposito I, Vitullo P, Salvi M, Troiani P, Ficili F, Parisi GF, Pantano S, Costa S, Leonetti G, Palladino N, Taccetti G, Bonomi P, Salvatore D. Terlizzi V, et al. Among authors: fevola c. J Pediatr. 2024 Nov;274:114228. doi: 10.1016/j.jpeds.2024.114228. Epub 2024 Aug 28. J Pediatr. 2024. PMID: 39198099 Free article. No abstract available.
Reported Adverse Events in a Multicenter Cohort of Patients Ages 6-18 Years with Cystic Fibrosis and at Least One F508del Allele Receiving Elexacaftor/Tezacaftor/Ivacaftor.
Terlizzi V, Fevola C, Presti S, Castaldo A, Daccò V, Claut L, Sepe A, Majo F, Casciaro R, Esposito I, Vitullo P, Salvi M, Troiani P, Ficili F, Parisi GF, Pantano S, Costa S, Leonetti G, Palladino N, Taccetti G, Bonomi P, Salvatore D. Terlizzi V, et al. Among authors: fevola c. J Pediatr. 2024 Nov;274:114176. doi: 10.1016/j.jpeds.2024.114176. Epub 2024 Jun 28. J Pediatr. 2024. PMID: 38945446
[Italian Cystic Fibrosis Registry (ICFR). Report 2021-2022].
Campagna G, Amato A, Majo F, Ferrari G, Quattrucci S, Padoan R, Floridia G, Salvatore D, Carnovale V, Puppo Fornaro G, Taruscio D, Salvatore M; Gruppo di lavoro RIFC. Campagna G, et al. Epidemiol Prev. 2024 Mar-Apr;48(2 Suppl 2):1-41. doi: 10.19191/EP24.2.S2.031. Epidemiol Prev. 2024. PMID: 38742380 Free article. Italian.
28 results